Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc.（VTYX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · VTYX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
3
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Ventyx Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
VTYX 季度内部人买卖趋势
VTYX 内幕交易卖出 · VTYX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · VTYX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
VTYX 高管卖出股份 · VTYX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 4, 2026 | Gonzales Roy Senior VP, Finance | Other | 5,313 | $74K | Form 4 |
| Mar 4, 2026 | Subramaniam Somu Director | Other | 3,337,495 | $46.72M⚡ | Form 4 |
| Mar 4, 2026 | GUJRATHI SHEILA Director | Other | 130,000 | $1.82M⚡ | Form 4 |
| Mar 4, 2026 | Nuss John CHIEF SCIENTIFIC OFFICER | Other | 489,481 | $6.85M⚡ | Form 4 |
| Mar 4, 2026 | Mohan Raju CEO AND PRESIDENT · Director | Other | 2,372,863 | $33.22M⚡ | Form 4 |
| Mar 4, 2026 | Forman Mark S Chief Medical Officer | Other | 6,000 | $84K | Form 4 |
| Feb 27, 2026 | Subramaniam Somu Director | Other | 694,718 | — | Form 4 |
| Dec 17, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Option | 116,668 | — | Form 4 |
| Dec 18, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Sale | 47,345 | $365K | Form 4 |
| Dec 17, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 34,930 | — | Form 4 |
| Dec 18, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 12,675 | $98K | Form 4 |
| Nov 17, 2025 | Forman Mark S Chief Medical Officer | Award | 3,000 | $3K | Form 4 |
| Nov 17, 2025 | Gonzales Roy Senior VP, Finance | Award | 1,767 | $2K | Form 4 |
| May 15, 2025 | Gonzales Roy Senior VP, Finance | Award | 1,750 | $2K | Form 4 |
| May 15, 2025 | Forman Mark S Chief Medical Officer | Award | 3,000 | $3K | Form 4 |
| Apr 2, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 1,887 | $2K | Form 4 |
| Mar 28, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Option | 11,844 | — | Form 4 |
| Mar 28, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 4,531 | — | Form 4 |
| Mar 28, 2025 | Subramaniam Somu Director | Other | 1,335,450 | — | Form 4 |
| Mar 10, 2025 | Subramaniam Somu Director | Other | 1,735,306 | — | Form 4 |
| Dec 27, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 21,119 | $50K | Form 4 |
| Dec 23, 2024 | Gujrathi Sheila Director | Purchase | 130,000 | $301K | Form 4 |
| Dec 17, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 34,930 | — | Form 4 |
| Dec 19, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 13,161 | $30K | Form 4 |
| Dec 17, 2024 | Mohan Raju CEO AND PRESIDENT · Director | Option | 116,668 | — | Form 4 |
Mohan Raju
CEO AND PRESIDENT · Director
日期
Mar 4
股数
2,372,863
均价
$14.00
总金额
$33.22M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 VTYX 内幕交易
VTYX 内幕交易
Ventyx Biosciences, Inc.（VTYX）内幕交易数据来源于公司内部人（包括Nuss John (CHIEF SCIENTIFIC OFFICER), Mohan Raju (CEO AND PRESIDENT · Director), Gonzales Roy (Senior VP, Finance)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。VTYX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Ventyx Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
VTYX 内幕交易 · 5个问题Ventyx Biosciences, Inc.（VTYX）的内部人包括高管和董事，如Nuss John (CHIEF SCIENTIFIC OFFICER), Mohan Raju (CEO AND PRESIDENT · Director), Gonzales Roy (Senior VP, Finance)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026